Pages that link to "Q46204111"
Jump to navigation
Jump to search
The following pages link to Comparison of the efficacy of dihydropyridine calcium channel blockers in African American patients with hypertension. ISHIB Investigators Group. International Society on Hypertension in Blacks (Q46204111):
Displaying 12 items.
- Gastrointestinal safety of an extended-release, nondeformable, oral dosage form (OROS: a retrospective study (Q28212356) (← links)
- Gastrointestinal Safety of an Extended-Release, Nondeformable, Oral Dosage Form (OROS??)* (Q29540930) (← links)
- The necessity for recognition and treatment of patients with "mild" hypertension (Q33768923) (← links)
- Modified-release nifedipine: a review of the use of modified-release formulations in the treatment of hypertension and angina pectoris (Q34566315) (← links)
- Combination therapy with renin-angiotensin system blockers: will amlodipine replace hydrochlorothiazide? (Q34581755) (← links)
- Clinical pharmacology of antihypertensive drugs (Q34742268) (← links)
- Effect of amlodipine on systolic blood pressure (Q35085365) (← links)
- How to treat hypertension in blacks: review of the evidence (Q37681475) (← links)
- Endstage renal disease owing to diabetic nephropathy in Mississippi: an examination of factors influencing renal survival in a population prone to late referral (Q43607148) (← links)
- Hypertensive cardiovascular disease in African Americans (Q46353950) (← links)
- Renal artery stenosis as a cause of renal impairment: implications for treatment of hypertension and congestive heart failure (Q73488432) (← links)
- Efficacy and tolerability of a switch to fixed-dose combination therapy with amlodipine besylate/benazepril hydrochloride after monotherapy with amlodipine besylate: Data from the African-American subpopulation of a practice-based, open-label study (Q88093188) (← links)